A Phase 0 Window of Opportunity Trial of LB100, a Protein Phosphatase 2A Inhibitor, in Patients with Recurrent Gliomas.
Saved in:
| Title: | A Phase 0 Window of Opportunity Trial of LB100, a Protein Phosphatase 2A Inhibitor, in Patients with Recurrent Gliomas. |
|---|---|
| Authors: | Burton EC; Neuro-oncology Branch, National Cancer Institutes, 9030 Old Georgetown Road, Building 82, Bethesda, MD 20892., Walker E; Neurosurgical Oncology Unit, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1414., Boris L; Neuro-oncology Branch, National Cancer Institutes, 9030 Old Georgetown Road, Building 82, Bethesda, MD 20892., Reyes J; Neuro-oncology Branch, National Cancer Institutes, 9030 Old Georgetown Road, Building 82, Bethesda, MD 20892., Fernandez K; Neuro-oncology Branch, National Cancer Institutes, 9030 Old Georgetown Road, Building 82, Bethesda, MD 20892., Wall K; Neuro-oncology Branch, National Cancer Institutes, 9030 Old Georgetown Road, Building 82, Bethesda, MD 20892., Wu J; Neuro-oncology Branch, National Cancer Institutes, 9030 Old Georgetown Road, Building 82, Bethesda, MD 20892., Schmidt KT; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Besthesda, MD 20892., Figg WD; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Besthesda, MD 20892., Brown DA; Neurosurgical Oncology Unit, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1414. |
| Source: | MedRxiv : the preprint server for health sciences [medRxiv] 2025 Aug 21. Date of Electronic Publication: 2025 Aug 21. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40894137 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Phase 0 Window of Opportunity Trial of LB100, a Protein Phosphatase 2A Inhibitor, in Patients with Recurrent Gliomas. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Burton+EC%22">Burton EC</searchLink>; Neuro-oncology Branch, National Cancer Institutes, 9030 Old Georgetown Road, Building 82, Bethesda, MD 20892.<br /><searchLink fieldCode="AU" term="%22Walker+E%22">Walker E</searchLink>; Neurosurgical Oncology Unit, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1414.<br /><searchLink fieldCode="AU" term="%22Boris+L%22">Boris L</searchLink>; Neuro-oncology Branch, National Cancer Institutes, 9030 Old Georgetown Road, Building 82, Bethesda, MD 20892.<br /><searchLink fieldCode="AU" term="%22Reyes+J%22">Reyes J</searchLink>; Neuro-oncology Branch, National Cancer Institutes, 9030 Old Georgetown Road, Building 82, Bethesda, MD 20892.<br /><searchLink fieldCode="AU" term="%22Fernandez+K%22">Fernandez K</searchLink>; Neuro-oncology Branch, National Cancer Institutes, 9030 Old Georgetown Road, Building 82, Bethesda, MD 20892.<br /><searchLink fieldCode="AU" term="%22Wall+K%22">Wall K</searchLink>; Neuro-oncology Branch, National Cancer Institutes, 9030 Old Georgetown Road, Building 82, Bethesda, MD 20892.<br /><searchLink fieldCode="AU" term="%22Wu+J%22">Wu J</searchLink>; Neuro-oncology Branch, National Cancer Institutes, 9030 Old Georgetown Road, Building 82, Bethesda, MD 20892.<br /><searchLink fieldCode="AU" term="%22Schmidt+KT%22">Schmidt KT</searchLink>; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Besthesda, MD 20892.<br /><searchLink fieldCode="AU" term="%22Figg+WD%22">Figg WD</searchLink>; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Besthesda, MD 20892.<br /><searchLink fieldCode="AU" term="%22Brown+DA%22">Brown DA</searchLink>; Neurosurgical Oncology Unit, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1414. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101767986%22">MedRxiv : the preprint server for health sciences</searchLink> [medRxiv] 2025 Aug 21. <i>Date of Electronic Publication: </i>2025 Aug 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Preprint – Name: TitleSource Label: Journal Info Group: Src Data: <i>Country of Publication: </i>United States <i>NLM ID: </i>101767986 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>NLM ISO Abbreviation: </i>medRxiv <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40894137 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1101/2025.08.18.25333496 Languages: – Code: eng Text: English Titles: – TitleFull: A Phase 0 Window of Opportunity Trial of LB100, a Protein Phosphatase 2A Inhibitor, in Patients with Recurrent Gliomas. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Burton EC – PersonEntity: Name: NameFull: Walker E – PersonEntity: Name: NameFull: Boris L – PersonEntity: Name: NameFull: Reyes J – PersonEntity: Name: NameFull: Fernandez K – PersonEntity: Name: NameFull: Wall K – PersonEntity: Name: NameFull: Wu J – PersonEntity: Name: NameFull: Schmidt KT – PersonEntity: Name: NameFull: Figg WD – PersonEntity: Name: NameFull: Brown DA IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 08 Text: 2025 Aug 21 Type: published Y: 2025 Titles: – TitleFull: MedRxiv : the preprint server for health sciences Type: main |
| ResultId | 1 |
